UnitedHealth (UNH.US) Q3 Results Exceed Expectations: Lower Medical Payout Ratio Boosts Profits, Full-Year Earnings Guidance Raised Again

According to Zhitong Finance APP, UnitedHealth (UNH.US) released its Q3 2026 earnings and raised its full-year earnings guidance. Adjusted earnings per share for the third quarter were $4.69, exceeding expectations, marking the third time this year the company has raised its full-year guidance to at least $20.50 per share. Quarterly revenue was $112.694 billion, down 0.4% year-on-year, but still higher than the market expectation of about $111 billion. Operating profit was $6.563 billion, up 52% year-on-year, with a net profit margin of 3.6%. The company is the first large U.S. healthcare group to report Q3 earnings, which are seen as an industry benchmark.

On the profit side, GAAP diluted earnings per share were $4.56, up 76% year-on-year;adjusted earnings per share—excluding items such as intangible asset amortization, asset disposals, and restructuring—were $4.69, up 61% year-on-year. According to analyst data compiled by LSEG, the market had expected adjusted earnings per share of $4.14, thus outperforming by $0.55. Net profit attributable to common shareholders was $4.11 billion, up 75% year-on-year.

Cost control was a major driver this quarter. The medical loss ratio was 88.4%, better than analysts' expectation of 89.9% and last year's 89.90%. The company attributes this to adjusted insurance product designs and new pricing. The company disclosed that this ratio includes a $610 million net favorable prior year reserve release—funds previously set aside for medical claims but ultimately unused. CFO Wayne DeVeydt stated that medical cost growth "remains elevated but is very stable." The operating expense ratio for the quarter decreased from 13.5% to 12.8%, and operating cash flow was $5.1 billion, 1.2 times net profit.

By business segment, the insurance division UnitedHealthcare posted revenue of $86.33 billion, down 0.9% year-on-year, with operating profit rising from $1.805 billion to $2.831 billion, and the profit margin rising from 2.1% to 3.3%. It served 48.3 million members. The health services division Optum posted revenue of $66.883 billion, down 3.3% year-on-year, with operating profit rising from $2.51 billion to $3.732 billion. Within this, Optum Health’s revenue fell 10% year-on-year to $22.91 billion due to serving fewer patients in markets lacking a value-based care foundation, but operating profit rebounded from $41 million to $735 million.

According to reports, Optum Health is contracting: earlier this year, the company said it would cut about 20% of its clinics, roughly 550 locations, most of which were closed in the first half, and the process will be completed by the end of 2026. DeVeydt said the goal is to transfer these clinics to new owners, not shut them down: "At this stage, we have no plans for closures." He also stated that Optum Health’s full-year operating profit will exceed $2.2 billion.

On the membership side, the company continues to deliberately shrink its scale. Employer and individual business lost 165,000 members this quarter, and community and state business saw an 85,000-member drop due to Medicaid eligibility changes. The company disclosed that since the end of 2025, senior members served through Medicare Advantage and related plans (including complex populations under Medicaid) have decreased by 935,000. UnitedHealth states that at least 69% of members are in four-star or higher rated plans in the 2027 Medicare Advantage star ratings, "in line with expectations," and mentioned improvements in 11 out of 12 HEDIS quality indicators. However, the federal government last week downgraded the quality ratings of some UnitedHealthcare plans, and analysts at Evercore ISI and TD Cowen estimate this could cut 2028 revenue by more than $1 billion. DeVeydt said membership is expected to grow again by 2027: "Is growth under consideration? We believe it is."

For guidance, the company raised its 2026 full-year adjusted earnings per share target to at least $20.50 (previously $19.50–$20.00) and its GAAP diluted earnings per share target to at least $19.50. This marks the third guidance raise by the company this year. According to LSEG data, analysts previously expected full-year 2026 earnings per share of $19.86; the new lower bound is now above consensus.

UnitedHealth CEO Stephen Hemsley stated that Q3 results "reflect the discipline and execution our team has shown across all areas of our business." The company also listed several initiatives focused on affordability, reforming prior authorization, and drug pricing transparency, including investing $1 billion in the United Health Foundation, eliminating 30% of existing prior authorization volume by the end of 2026, and passing 100% of pharmaceutical rebates to customers starting January 2028.

This round of guidance increases marks the latest step in the company’s transformation. Over the past two years, UnitedHealth has faced the largest cyberattack in U.S. healthcare history, failed to meet financial targets, was briefly forced to withdraw its earnings guidance, replaced several senior executives, and exited some health insurance product lines. The company previously stated that its Optum unit faces regulatory and cost challenges, with about $11 billion in impact to this subsidiary over three years. According to Bloomberg, the company is also seeking private equity assistance for operating some physician clinics. With forthcoming federal policy changes such as the 2027 Medicaid work requirements, uncertainty will further increase.

Driven by the earnings beat and guidance raise, UnitedHealth's stock rose pre-market on October 13. At the time of publication, the share price was up 2.5% pre-market to about $388. The report also boosted shares of UnitedHealth’s industry peers, including Humana (HUM.US), CVS Health (CVS.US), Centene (CNC.US), Alignment Healthcare (ALHC.US), and Elevance Health (ELV.US).